The Artemis II astronauts are more than halfway to the moon. The three Americans and one Canadian will reach their ...

A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe ...

From 'translunar injection' to 'sphere of influence,' here are the terms to know as the Artemis II astronauts approach the ...

NASA's Artemis II mission is moonbound in the Orion capsule. Here's a glossary of terms to help you understand the upcoming ...

The Artemis II mission, which launched April 1 from Florida, got the greenlight to begin its lunar journey after a day or ...

With the last major firing of its engine, the Artemis II spacecraft is now on a path that will take it around the moon and ...

"Humanity has once again shown what we are capable of, and it's your hopes for the future that carry us now on this journey ...

For the U.S. space agency, this moment is the real point of no return in a carefully orchestrated test flight. It's the last ...

The Artemis II astronauts, after saying goodbye to family and friends, were strapped into their seats aboard the Orion ...

After a day of testing the Orion capsule high above the planet, the crew of the NASA mission became the first people to head ...

Novo Nordisk (NVO) faces rising GLP-1 competition from Eli Lilly; see pipeline catalysts, patent risks, and a $29/share fair ...

April 1 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to corner a share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will ...